Drug News Male hormone boosts women’s libido, but potentially risky
By Jimmy Downs
Nov 7, 2008 - 12:03:54 PM
If you like the article, could you please do us a favor? Just tell Google News Services that you like foodconsumer.org included in Google News Services. Inclusion in googlenewsservices means many more people can read articles like this. Thanks.
------
Friday November 7, 2008 (foodconsumer.org) -- A study
published in the Sep 2008 issue of the Journal of Sexual Medicine suggests that
testosterone therapy may be used to improve all domains of sexual function in
postmenopausal women who experience hypoactive sexual desire disorder (HSDD).
The review study found "Surgically menopausal women
receiving testosterone experience significant increases in total satisfying
sexual activity vs. women receiving placebo, significant improvement in all
domains of sexual function, and decreases in personal distress, with a
favorable safety profile."
The review by Kingsberg S. A. and colleagues of Case
Western Reserve University School of Medicine covered research on the
physiologic effects of testosterone in postmenopausal women, the effects of transdermal
testosterone delivery in surgically menopausal women with HSDD, and ongoing
studies of a transdermal testosterone gel.
An estimated 20 to 53 percent of all women in the United
States suffer hypoactive sexual desire disorder. The problem is particularly obvious
among women who experience surgical menopause.
This condition is often associated with a decrease in androgen levels as
a result of aging or bilateral oophorectomy and because of this it is believed
that use of testosterone boosts sexual desire in postmenopausal women.
The researchers concluded "Testosterone deficiency
may be considered among the underlying causes of HSDD."
One recent trial led by Susan Davis of Monash University
in Melbourne, Australia and colleagues further confirmed that testosterone may
be used to treat HSDD in postmenopausal women.
The trial showed use of 300 micrograms of testosterone
per day through Intrinsa testosterone patches made by Procter & Gamble
doubled the monthly sexual episodes in women.
The only problem with this testosterone treatment is the
side or adverse effects. The adverse effects observed during the one-year trial
included an increased risk of breast cancer and hair growth.
Breast cancer was diagnosed in four of the
534 women treated with the male hormone, but none in the 277 placebo recipients.
The study was published in
the November 2008 issue of the New England Journal
of Medicine.
Currently, testosterone is available to women in the
United States only via off-label prescribing or by unregulated compounding of
testosterone preparations, according to Kingsberg.
Long term trials are needed to evaluate the
long-term safety of the testosterone patch in women with HSDD.
In addition to the testosterone patches, women who have concerns
about their sex life may consider changing their lifestyle.
Stresses, lack of physical activity, unhealthy
diet and many types of medications have been known to have a negative impact on
their sexual life.